Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 1
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Mastijet Forte - V/NRP/96/0344 Intervet International B.V., Nīderlande QJ51RV01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Bacitracin,Neomycin,Prednisolone,Tetracycline hydrochloridum
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2018)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2018)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0344-01 20 Injektors, 1 deva [PDF] [PDF]
T61 - V/NRP/02/1429 Intervet International B.V., Nīderlande QN51AX50 guinea pigs; hamsters; cattle; pigs; horses; mouses; rats; dogs; cats; rabbits; minks; pigeons Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Embutramide, Mebezonium iodide, Tetracaine hydrohchloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International GmbH, Vācija
Date of authorisation/renewal: 14-Aug-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1429-01 1 Stikla pudele (dzintarkrāsas), 50 ml -
Hefrotrim - V/NRP/95/0251 Alivira Animal Health Limited,, Īrija QJ01EW03 cattle; pigs; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Trimethoprim, Sulfadimidine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Karizoo S.A., Spānija
Date of authorisation/renewal: 04-Apr-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/95/0251-01 1 Stikla pudelīte, 50 ml -
V/NRP/95/0251-02 1 Stikla flakons, 100 ml -
V/NRP/95/0251-03 10 Stikla pudelīte, 50 ml -
V/NRP/95/0251-04 12 Stikla flakons, 100 ml -
Ingelvac MycoFLEX - V/MRP/09/0014 Boehringer Ingelheim Vetmedica GmbH, Vācija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Mycoplasma hyopneumoniae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0014-08 12 ABPE pudele, 250 ml -
V/MRP/09/0014-09 1 ABPE pudele, 50 ml -
V/MRP/09/0014-10 1 ABPE pudele, 10 ml -
V/MRP/09/0014-11 12 ABPE pudele, 10 ml -
V/MRP/09/0014-12 12 ABPE pudele, 50 ml -
V/MRP/09/0014-13 1 ABPE pudele, 250 ml -
V/MRP/09/0014-14 1 ABPE pudele, 100 ml -
V/MRP/09/0014-15 12 ABPE pudele, 100 ml -
V/MRP/09/0014-16 12 ABPE TwistPak pudele, 250 ml -
V/MRP/09/0014-17 1 ABPE TwistPak pudele, 50 ml -
V/MRP/09/0014-18 1 ABPE TwistPak pudele, 10 ml -
V/MRP/09/0014-19 12 ABPE TwistPak pudele, 10 ml -
V/MRP/09/0014-20 12 ABPE TwistPak pudele, 50 ml -
V/MRP/09/0014-21 1 ABPE TwistPak pudele, 250 ml -
V/MRP/09/0014-22 1 ABPE TwistPak pudele, 100 ml -
V/MRP/09/0014-23 12 ABPE TwistPak pudele, 100 ml -
Avishield ND B1 - V/DCP/18/0017 Izo S.r.l., Itālija QI01AD06 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Live Newcastle dis.virus str.Hitchner B1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Genera d.d., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0017-01 10 Stikla flakons, 1000 deva -
V/DCP/18/0017-02 10 Stikla flakons, 2500 deva -
V/DCP/18/0017-03 10 Stikla flakons, 5000 deva -
Avishield IB QX - V/DCP/25/0049 Izo S.r.l., Itālija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oculonasal suspension/use in drinking water
International name (active substance): Avian infectious bronchitis virus, type QX, strain 1285, Live
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Genera d.d., Horvātija
Date of authorisation/renewal: 10-Jul-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Jan-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0049-01 10 Stikla flakons, 1000 deva -
V/DCP/25/0049-02 10 Stikla flakons, 2500 deva -
V/DCP/25/0049-03 10 Stikla flakons, 5000 deva -
Bimacure 500 mg V/DCP/22/0029 Bimeda Animal Health Limited, Īrija QG51AA05 cattle Vairāk

Medicinal product information

Pharmaceutical form: intrauterine suspension
International name (active substance): Cephapirin benzathine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma France, Francija
Date of authorisation/renewal: 27-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0029-01 10 polietilēna šļirce, 19 g -
BIOSUIS Entero - V/DCP/24/0028 Bioveta a.s., Čehija QI09AL09 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Porcine rotavirus, serogroup A, strain OSU 6, Inactivated, Escherichia coli, serotype O149:K88 (fimbrial adhesin F4ac), Inactivated, Escherichia coli, serotype O101:K99 (fimbrial adhesins F5 and F41), Inactivated, Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated, Clostridium perfringens, type C, beta toxoid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta a.s., Čehija
Date of authorisation/renewal: 10-Apr-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0028-01 1 Stikla flakons, 10 ml -
V/DCP/24/0028-02 1 Stikla flakons, 50 ml -
V/DCP/24/0028-03 1 Stikla flakons, 100 ml -
V/DCP/24/0028-04 1 ABPE flakons, 50 ml -
V/DCP/24/0028-05 1 ABPE flakons, 100 ml -
V/DCP/24/0028-06 1 ABPE flakons, 250 ml -
V/DCP/24/0028-07 10 Stikla flakons, 10 ml -
Karbetocin Bioveta 0.07 mg/ml V/DCP/25/0072 Bioveta a.s., Čehija QH01BB03 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carbetocin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 05-Dec-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (05-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (05-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0072-01 1 Stikla flakons, 10 ml -
V/DCP/25/0072-02 1 Stikla flakons, 50 ml -
Kelevo 800 µg/tabl. V/DCP/21/0032 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0032-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-02 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-03 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0032-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0032-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0032-06 4 Alumīnija blisteris, 25 tablete -
Kelevo 400 µg/tabl. V/DCP/21/0033 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0033-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-02 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0033-03 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0033-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0033-06 4 Alumīnija blisteris, 25 tablete -
Kelevo 200 µg/tabl. V/DCP/21/0034 Industrial Veterinaria, S.A., Spānija QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0034-01 5 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-02 10 Alumīnija blisteris, 25 tablete -
V/DCP/21/0034-03 10 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-04 25 Alumīnija blisteris, 10 tablete -
V/DCP/21/0034-05 2 Alumīnija blisteris, 25 tablete -
V/DCP/21/0034-06 4 Alumīnija blisteris, 25 tablete -
Ketosol-100 100 mg/ml V/MRP/18/0035 Interchemie Werken De Adelaar Eesti AS, Igaunija QM01AE03 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 30-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0035-01 1 Stikla flakons, 100 ml -
V/MRP/18/0035-02 1 Stikla flakons, 50 ml -
Ketabel 100 mg/ml V/DCP/20/0038 Bela-pharm GmbH&Co.KG, Vācija QN01AX03 guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0038-01 1 Stikla flakons, 10 ml -
V/DCP/20/0038-02 10 Stikla flakons, 10 ml -
V/DCP/20/0038-03 1 Stikla flakons, 25 ml -
V/DCP/20/0038-04 10 Stikla flakons, 25 ml -
Biomectin 1% 10 mg/ml V/NRP/96/0466 Vetoquinol Biowet Sp. z o.o., Polija QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0466-01 10 mg/ml 1 Stikla flakons, 20 ml -
V/NRP/96/0466-02 10 mg/ml 1 Stikla flakons, 50 ml -
V/NRP/96/0466-03 10 mg/ml 1 Stikla flakons, 100 ml -
V/NRP/96/0466-04 10 mg/ml 1 Stikla flakons, 250 ml -
V/NRP/96/0466-05 10 mg/ml 1 Plastmasas flakons, 500 ml -
Zoletil 100 - V/NRP/07/1711 Virbac S.A., Francija QN01AX99 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Zolazepam hydrochloride, Tiletamine hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 15-Jan-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 11112025LI (11-Nov-2025)
Labelling text: [DOCX] 11112025M (11-Nov-2025)
Summary of product characteristics: [DOCX] 11112025ZA (11-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1711-01 1 Flakons (šķīdinātājs), 5 ml;Flakons (liofilizāts), 970 mg -
Fypryst 402 mg - V/DCP/10/0010 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0010-01 402 mg 3 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-02 402 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-03 402 mg 6 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-04 402 mg 10 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0010-05 402 mg 20 Plastikāta tūbiņa, 1 deva -
Trymox LA 150 mg/ml V/DCP/19/0019 Univet Ltd., Īrija QJ01CA04 cattle; pigs; sheep; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0019-01 150 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/19/0019-02 150 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/19/0019-03 150 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/19/0019-04 150 mg/ml 1 PET pudele, 100 ml -
V/DCP/19/0019-05 150 mg/ml 1 PET pudele, 250 ml -
V/DCP/19/0019-06 150 mg/ml 12 Stikla flakons, 50 ml -
V/DCP/19/0019-07 150 mg/ml 12 Stikla flakons, 100 ml -
V/DCP/19/0019-08 150 mg/ml 12 PET pudele, 100 ml -
V/DCP/19/0019-09 150 mg/ml 6 Stikla flakons, 250 ml -
V/DCP/19/0019-10 150 mg/ml 6 PET pudele, 250 ml -
Telmitraxx 4 mg/ml V/DCP/23/0024 Alfasan Nederland BV, Nīderlande QC09CA07 cats Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Telmisartan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-Jun-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0024-01 1 ABPE pudele, 30 ml -
V/DCP/23/0024-02 1 ABPE pudele, 60 ml -
V/DCP/23/0024-03 1 ABPE pudele, 90 ml -
V/DCP/23/0024-04 1 ABPE pudele, 200 ml -
Vetmedin S 2.5 mg V/MRP/15/0012 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Jan-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0012-01 2,5 mg 2 PVH/Al blisteris, 10 tablete -
V/MRP/15/0012-02 2,5 mg 5 PVH/Al blisteris, 10 tablete -
V/MRP/15/0012-03 2,5 mg 10 PVH/Al blisteris, 10 tablete -

3082 records